Can Algal Derived Bioactive Metabolites Serve as Potential Therapeutics for the Treatment of SARS-CoV-2 Like Viral Infection?
- PMID: 33262750
- PMCID: PMC7686535
- DOI: 10.3389/fmicb.2020.596374
Can Algal Derived Bioactive Metabolites Serve as Potential Therapeutics for the Treatment of SARS-CoV-2 Like Viral Infection?
Keywords: COVID-19; antiviral; microalgae; seaweed; sulphated polysaccharides.
Figures
References
-
- Aguilar-Briseño J., Cruz-Suarez L., Sassi J. F., Ricque-Marie D., Zapata-Benavides P., Mendoza-Gamboa E., et al. . (2015). Sulphated polysaccharides from Ulva clathrata and Cladosiphon okamuranus seaweeds both inhibit viral attachment/entry and cell-cell fusion, in NDV infection. Mar. Drugs 13, 697–712. 10.3390/md13020697 - DOI - PMC - PubMed
-
- Cascella M., Rajnik M., Cuomo A., Dulebohn S. C., Di Napoli R. (2020). Features, Evaluation and Treatment Coronavirus (COVID-19). Florida: StatPearls Publishing. - PubMed
-
- Costa J. A. V., Moreira J. B., Fanka L. S., da Kosinski R. C., de Morais M. G. (2020). “Microalgal biotechnology applied in biomedicine,” in Handbook of Algal Science, Technology and Medicine, ed O. Konur (Rio Grande, TX: Elsevier; ), 429–439.
LinkOut - more resources
Full Text Sources
Miscellaneous